Determination of bone markers in pycnodysostosis: Effects of cathepsin K deficiency on bone matrix degradation

Journal of Bone and Mineral Research

Volumn 14, Issue 11, 1999, Pages 1902-1908

  Nishi, Yoshikazu ^a   Atley, Lynn ^b   Eyre, David E ^b   Edelson, Jacob G ^c   Superti Furga, Andrea ^d   Yasuda, Toshiyuki ^e   Desnick, Robert J ^f   Gelb, Bruce D ^f  

^a ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Poriya Hospital   (Israel)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; BIOCHEMICAL MARKER; CATHEPSIN K; COLLAGEN TYPE 1; COLLAGENASE; CYSTEINE PROTEINASE; LYSOSOME ENZYME; OSTEOCALCIN; TARTARIC ACID;

ADOLESCENT; ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BONE DYSPLASIA; BONE MATRIX; BONE METABOLISM; CARBOXY TERMINAL SEQUENCE; CHILD; CLINICAL ARTICLE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; DEGRADATION; DYSOSTOSIS; ENZYME ACTIVITY; ENZYME DEFICIENCY; HUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OSTEOSCLEROSIS;

ACID PHOSPHATASE; ADOLESCENT; ADULT; AMINO ACIDS; BIOLOGICAL MARKERS; BONE AND BONES; BONE MATRIX; CATHEPSINS; CHILD; COLLAGEN; COLLAGEN TYPE I; HUMANS; ISOENZYMES; MUTAGENESIS; OSTEOCALCIN; OSTEOSCLEROSIS; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN;

EID: 0032714266     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.11.1902     Document Type: Article

References (39)

1. Gelb BD, Shi GP, Chapman HA, Desnick RJ 1996 Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236-1238.
2. Maroteaux P, Lamy M 1962 La pycnodysostose. Presse Med 70:999-1002.
3. Andren L, Dymling JF, Hogeman KE, Wendeberg B 1962 Osteopetrosis acro-osteolytica: A syndrome of osteopetrosis, acro-osteolysis and open sutures of the skull. Acta Chir Scand 124:496-507.
4. Tezuka K, Tezuka Y, Maejima A, Sato T, Nemoto K, Kamioka H, Hakeda Y, Kumegawa M 1994 Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem 269:1106-1109.
5. Inaoka T, Bilbe G, Osamu I, Tezuka K-I, Kumegawa M, Kokubo T 1995 Molecular cloning of human cDNA for cathepsin K: Novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Commun 206:89-96.
6. Shi G-P, Chapman HA, Bhairi SM, DeLeeuw C, Reddy VY, Weiss SJ 1995 Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett 357:129-134.
7. Brömme D, Okamoto K 1995 Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary: Molecular cloning, sequencing and tissue distribution. Biol Chem Hoppe-Seyler 376:379-384.
8. Li Y-P, Alexander M, Wucherpfennig AL, Yelick P, Chen W, Stashenko P 1995 Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas. J Bone Miner Res 10:1197-1202.
9. Everts V, Aronson DC, Beertsen W 1985 Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis. Calcif Tissue Int 37:25-31.
10. Littlewood-Evans A, Kokubo T, Ishibashi O, Inaoka T, Wlodarski B, Gallagher JA, Bilbe G 1997 Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone 20:81-86.
11. Kamiya T, Kobayashi Y, Kanaoka K, Nakashima T, Kato Y, Mizuno A, Sakai H 1998 Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts. J Biochem 123:752-759.
12. Dodds RA, Connor JR, Drake F, Field J, Gowen M 1998 Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development. J Bone Miner Res 13:673-682.
13. Yamaza T, Goto T, Kamiya T, Kobayashi Y, Sakai H, Tanaka T 1998 Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur. Bone 23:499-509.
14. Brömme D, Okamoto K, Wang BB, Biroc S 1996 Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. J Biol Chem 271:2126-2132.
15. Hou W-S, Brömme D, Zhao Y, Mehler E, Dushey C, Weinstein H, Sa Miranda C, Fragge C, Greig F, Carey J, Rimoin D, Desnick RJ, Gelb BD 1999 Cathepsin K: Characterization of novel mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest 103:731-738.
16. Sedano HP, Gorlin RJ, Anderson VE 1968 Pycnodysostosis: Clinical and genetic considerations. Am J Dis Child 116:70-77.
17. Diego EMD, Guerrero R, de la Piedra C 1994 Six osteocalcin assays compared. Clin Chem 40:2071-2077.
18. Hosoda K, Eguchi H, Nakamoto T, Kubota T, Honda H, Jindai S, Hasegawa R, Kiyoki M, Yamaji T, Shiraki M 1992 Sandwich immunoassay for intact human osteocalcin. Clin Chem 38:2233-2238.
19. Babson AL, Read PA, Phillips GE 1959 The importance of the substrate in assays of acid phosphatase in serum. Am J Clin Pathol 32:83-87.
20. Lau KHW, Onishi T, Wergedal JE, Singer FR, Baylink DJ 1987 Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin Chem 33:458-462.
21. Hanson DA, Weis MAE, Bollen A-M, Maslan SL, Singer FR, Eyre DR 1992 A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 7:1251-1258.
22. Edelson JG, Obad S, Geiger R, On A, Artul HJ 1992 Pycnodysostosis: Orthopedic aspects with a description of 14 new cases. Clin Orthop 280:263-276.
23. Gelb BD, Edelson JG, Desnick RJ 1995 Linkage of pycnodysostosis to chromosome 1q21 by homozygosity mapping. Nat Genet 10:235-237.
24. Garner P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD, Delaisse J-M 1998 The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273:32347-32352.
25. Kafienah W, Brömme D, Buttle DJ, Croucher LJ, Hollander AP 1998 Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 331:727-732.
26. Brenner RE, Vetter U, Bollen A-M, Morike M, Eyre DR 1994 Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta. J Bone Miner Res 9:993-997.
27. Hernandez MV, Peris P, Guanabens N, Alvarez L, Monegal A, Pons F, Ponce A, Munoz-Gome J 1997 Biochemical markers of bone turnover in Camurati-Engelmann disease: A report on four cases in one family. Calcif Tissue Int 61:48-51.
28. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C 1994 Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 40:2022-2025.
29. Nesbitt SA, Horton MA 1997 Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276:266-269.
30. Salo J, Lehenkari P, Mulari M, Metsikkö K, Väänänen HK 1997 Removal of osteoclast bone resorption products by transcytosis. Science 276:270-273.
31. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L 1993 Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39:635-640.
32. Risteli J, Sassi M-L, Eriksen H, Niemi S, Mansell JP, Risteli L 1997 Epitope of the assay for the carboxyterminal telopeptide of human type I collagen (ICTP). J Bone Miner Res 12:S498.
33. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J 1993 Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry. J Bone Miner Res 8:127-132.
34. Garner P, Shi WJ, Gineyts E, Karpf DB, Delmas PD 1994 Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693-1700.
35. Sairanen S, Tahtela R, Laitinen K, Loyttyniemi E, Valimaki MJ 1997 Effects of short-term treatment with clodronate on parameters of bone metabolism and their diurnal variation. Calcif Tissue Int 60:160-163.
36. Eyre DR 1997 Bone biomarkers as tools in osteoporosis management. Spine 22:17S-24S.
37. Apone S, Lee MY, Eyre DR 1997 Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone. Bone 21:129-136.
38. Colwell A, Eastell R 1996 The renal clearance of free and conjugated pyridinium cross-links of collagen. J Bone Miner Res 11:1976-1980.
39. Beaidsworth LJ, Eyre DR, Dickson IR 1990 Changes with age in the urinary excretion of lysyl- and hydroxylysyl-pyridinoline: Two new markers of bone collagen turnover. J Bone Miner Res 5:671-676.